Yesterday, Sarepta Therapeutics announced that the FDA has issued a Clinical Hold letter for the company’s phase I/II trial testing the safety and …

July 26, 2018 by abzali123
Yesterday, Sarepta Therapeutics announced that the FDA has issued a Clinical Hold letter for the company’s phase I/II trial testing the safety and …
Action Duchenne
5th Floor, Mariner House
62 Prince Street
Bristol
BS1 4QD
07535 498 506
info@actionduchenne.org
